Delivery Order SPE2DB20D2104-SPE2DB24FT93T

Award Date 4/30/24
Potential Completion Date 5/1/24
Potential Value $1.7K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with an ID of SPE2DB22D1106|SPE2DB23FEEQ4, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,417.78 firm-fixed-price delivery order is for the supply of 4 mg Naloxone Hydrochloride nasal spray, a critical medication used to reverse opioid overdoses. This award is not designated as a set-aside contract. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at up...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,105.98 firm-fixed-price delivery order is for the supply of 4 mg Naloxone hydrochloride nasal spray. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products...
This federal contract award, SPE2DB22D3016|SPE2DB24FAET8, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $3,533.12, is for the delivery of 4562987109 - NALOXONE HCL 4 MG NASAL SPRAY 2S, a critical opioid overdose reversal medication. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a value of $4,152.76 and is for the delivery of 4,557,205,143 units of Naloxone HCL 4 mg nasal spray. The contract was awarded on May 12, 2022, with a completion date of May 13, 2022. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up...
This federal contract award, valued at $4,707.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,560,941,949 units of Naloxone HCL 4 mg Nasal Spray, a critical medication used to reverse opioid overdoses. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of 4,562,139,657 units of Naloxone HCl 4 mg Nasal Spray, a critical medication used for the treatment of opioid overdose. The contract has a ceiling value of $1,199.86 and a completion date of September 13, 2023. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (DO) with a Firm Fixed Price (FFP) type, valued at $17,468.20. The award is from the Defense Logistics Agency (DLA) for the supply of 4 mg Naloxone Hydrochloride Nasal Spray, a critical medication used to treat opioid overdose. The contract has an ultimate completion date of December 5, 2023 and was awarded on December 4, 2022. This DO is part of a larger Indefinite Delivery Contract...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to provide 4,558,986,354 units of Naloxone HCL 4 mg nasal spray. The contract has a ceiling value of $11,337.85 and an ultimate completion date of November 4, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc., valued at up to $999,999,999.00 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $16,423.60, is for the delivery of 4562204431 units of 4mg Naloxone nasal spray. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between the DLA and Cencora, Inc., valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award is for the delivery of Naloxone HCL 4 mg nasal spray, a critical medical product used for the treatment and prevention of opioid overdose. The contract has a total ceiling value of $2,857.51 and is structured as a Firm Fixed Price Delivery Order, with a completion date of May 2, 2023. The contract is not designated with any...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB24FT93T
    Delivery Order

This federal contract award, with ID SPE2DB20D2104|SPE2DB24FT93T, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,693.49 delivery order contract is for the supply of 4 mg Naloxone Hydrochloride nasal spray, a critical medication used for the emergency treatment of opioid overdose. The contract has a firm fixed price pricing type and an ultimate completion date of May 1, 2024.

This award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for Cencora, Inc. to deliver a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions worldwide. The contract does not have a set-aside designation, indicating that it was awarded through full and open competition.

Generated 5/16/25, 12:42 PM